loader
Please Wait
Applying Filters...

Seqens Seqens

X

List of All Manufacturers & Suppliers for 205626 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Left Arrow
Right Arrow
Filters Filter
Cross PopUp
FILTER :

filter

01 LAMIVUDINE; NEVIRAPINE; ZIDOVUDINE (1)

filter

01 MICRO LABS (1)

filter

01 TABLET;ORAL (1)

filter

01 150MG;200MG;300MG (1)

filter

01 USA (1)

URL Supplier Web Content
TABLET;ORAL
150MG;200MG;300MG
LAMIVUDINE, NEVIRAPINE...
USA
205626
2018-08-13
DISCN
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for CTD TGA MCC DOSSIER APPLICATION 205626

Looking for CTD TGA MCC DOSSIER APPLICATION 205626 1

19

Micro Labs Limited, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

One of their notable products is LAMIVUDINE; NEVIRAPINE; ZIDOVUDINE, with a corresponding application number 205626 and regulatory information .

proudly manufactured in the

approval since 2018-08-13

Micro Labs Limited's LAMIVUDINE, NEVIRAPINE AND ZIDOVUDINE TABLET;ORAL, medication with 150MG;200MG;300MG of LAMIVUDINE; NEVIRAPINE; ZIDOVUDINE.

Post Enquiry
POST ENQUIRY